Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-018120
Filing Date
2021-05-04
Accepted
2021-05-04 16:31:43
Documents
1
Period of Report
2021-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11135
  Complete submission text file 0000899243-21-018120.txt   12717
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2420 SANDHILL ROAD, SUITE 203 MENLO PARK CA 94025
Business Address 2420 SANDHILL ROAD, SUITE 203 MENLO PARK CA 94025 650-228-8245
Taiho Ventures LLC (Reporting) CIK: 0001857906 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 21889033